Myokardia Inc (MYOK) Stock Price, Quote, News and Overview
NASDAQ:MYOK - Nasdaq -
MYOK Quote, Performance and Key Statistics
224.91
+0.11 (+0.05%)
The current stock price of MYOK is 224.91 null. In the past month the price increased by 1.34%. In the past year, price increased by 267.02%.
About MYOK
Company Profile
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.
Company Info
Myokardia Inc
1000 SIERRA POINT PARKWAY
BRISBANE CA 94005
CEO: T. Anastasios Gianakakos
Phone: 650-741-0900
Myokardia Inc / MYOK FAQ
What is the stock price of Myokardia Inc today?
The current stock price of MYOK is 224.91 null. The price increased by 0.05% in the last trading session.
What is the ticker symbol for Myokardia Inc stock?
The exchange symbol of Myokardia Inc is MYOK and it is listed on the Nasdaq exchange.
On which exchange is MYOK stock listed?
MYOK stock is listed on the Nasdaq exchange.
What is Myokardia Inc worth?
Myokardia Inc (MYOK) has a market capitalization of 11.99B null. This makes MYOK a Large Cap stock.
What are the support and resistance levels for Myokardia Inc (MYOK) stock?
Myokardia Inc (MYOK) has a support level at 224.9 and a resistance level at 224.92. Check the full technical report for a detailed analysis of MYOK support and resistance levels.
Should I buy Myokardia Inc (MYOK) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MYOK, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MYOK, evaluating the profitability, health, valuation and growth aspects
- Myokardia Inc (MYOK) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Myokardia Inc (MYOK) Sales and EPS estimates to see what analysts future expectations are.
- Myokardia Inc (MYOK) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Myokardia Inc (MYOK) Insider and Institutional Ownership to learn about the owners and their transactions.
- Myokardia Inc (MYOK) Stock Chart to make your own analysis
- Myokardia Inc (MYOK) Latest news and press-releases to stay up to date.
Does Myokardia Inc (MYOK) stock pay dividends?
MYOK does not pay a dividend.
What is the Price/Earnings (PE) ratio of Myokardia Inc (MYOK)?
Myokardia Inc (MYOK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.64).
MYOK Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MYOK. When comparing the yearly performance of all stocks, MYOK is one of the better performing stocks in the market, outperforming 98.38% of all stocks.
MYOK Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MYOK. MYOK has a great financial health rating, but its profitability evaluates not so good.
MYOK Financial Highlights
Over the last trailing twelve months MYOK reported a non-GAAP Earnings per Share(EPS) of -5.640000000000001. The EPS decreased by -61.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.74% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
MYOK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 64% to MYOK. The Buy consensus is the average rating of analysts ratings from 9 analysts.